Share on StockTwits

Udg Healthcare PLC (LON:UDG)‘s stock had its “buy” rating restated by Goodbody Stockbrokers Ltd in a research note issued on Monday.

A number of other firms have also recently commented on UDG. Analysts at Davy Research reiterated an “outperform” rating on shares of Udg Healthcare PLC in a research note on Monday. Separately, analysts at Investec raised their price target on shares of Udg Healthcare PLC from GBX 360 ($6.02) to GBX 365 ($6.10) in a research note on Monday. They now have a “hold” rating on the stock. Finally, analysts at N+1 Singer reiterated a “buy” rating on shares of Udg Healthcare PLC in a research note on Monday. They now have a GBX 410 ($6.85) price target on the stock. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of GBX 381.25 ($6.37).

Udg Healthcare PLC (LON:UDG) opened at 342.40 on Monday. Udg Healthcare PLC has a 1-year low of GBX 293.30 and a 1-year high of GBX 380.10. The stock has a 50-day moving average of GBX 347.8 and a 200-day moving average of GBX 351.3. The company’s market cap is £826.6 million.

UDG Healthcare plc is an international provider of services to healthcare manufacturers and pharmaceutical retailers.

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.